Products for Research Use Only
RegisterLogin

G13Ci-22

CAT: 0804-HY-179534Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-179534Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
G13Ci-22 is a MRTX1133 based KRAS G13C inhibitor. G13Ci-22 can be used for non-small cell lung cancer (NSCLC) research[1].
UNSPSC
12352005
Target
Ras
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Field of Research
Cancer
Smiles
O=C(C1=CC=CC(NC(C=C)=O)=C1)N2[C@@H]3CN(C4=C(C=NC(C5=CC(O)=CC6=C5C(C#C)=C(F)C=C6)=C7F)C7=NC(OC[C@@]89CCCN8C[C@H](F)C9)=N4)C[C@H]2CC3
Molecular Formula
C43H38F3N7O4
Molecular Weight
773.80
References & Citations
[1]Kirschner T, et al. Targeting KRASG13C with cyclic linker based inhibitors to explore warhead orientation. Sci Rep. 2025 Oct 31;15 (1) :38213.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-W459528-0122-Methoxy-22-oxodocosanoic acid
HY-W046348-0122- (tert-Butoxy) -22-oxodocosanoic acid
HY-175869Ferroptosis-IN-22
HY-168212PDE4-IN-22
HY-157384BChE-IN-22
HY-157516-01CDK2-IN-22
HY-161983Neuraminidase-IN-22
HY-149031DHODH-IN-22
HY-153950CDK7-IN-22
HY-158681PARP1-IN-22

Alternative Products

CatalogName
GTR19274443-01G13Ci-22
TRC-B119586-25MGDocosanoic-22,22,22-d3 Acid
I8443-18NInterleukin 22 (IL-22)
377428IL-22 (Interleukin-22)
MBS590062-01Interleukin-22 (IL-22)
IEK209-0122
MBS393859-01Docosahexaenoic-21,21,22,22,22-D5 Acid
RC252-33IL-22, Interleukin-22, rat
RC212-33IL-22, Interleukin-22, human
A0859-40HADAM 22 (A Disintegrin And Metalloproteinase 22)

Popular Products